Skip to main content

Effective Date: June 24, 2026 · Last Updated: June 24, 2026

1. Introduction

Cannabis Investor News ("CIN," "we," "us," or "our") is operated by CanIDeal. This Privacy Policy explains how we collect, use, disclose, and safeguard information when you visit www.cannabisinvestornews.co or interact with our daily market briefings, custom intelligence requests, or related services.

We are a publisher of cannabis market intelligence. We are not a broker-dealer, investment adviser, or fiduciary. By using the Site, you consent to the practices described below.

2. Information We Collect

We collect information in the following categories:

3. How We Use Information

4. Sharing and Disclosure

We do not sell personal information. We share information only with:

5. Your Rights

Depending on your jurisdiction (including California under CCPA/CPRA and the European Economic Area under GDPR), you may have the right to access, correct, delete, or port your personal information, to opt out of certain sharing, and to lodge a complaint with a supervisory authority. To exercise these rights, contact privacy@cannabisinvestornews.co.

You may unsubscribe from any marketing email by clicking the unsubscribe link in the footer of that email.

6. Data Retention & Security

We retain personal information only as long as necessary to fulfill the purposes described above and to meet legal, accounting, or reporting obligations. We use industry-standard administrative, technical, and physical safeguards. No method of transmission over the Internet is 100% secure.

7. Children

The Site is not intended for individuals under 18. We do not knowingly collect personal information from children.

8. Changes to This Policy

We may update this Policy from time to time. The "Last Updated" date above will reflect the most recent revision. Material changes will be communicated via the Site or email.

9. Contact

Questions about this Policy or our data practices: privacy@cannabisinvestornews.co · Contact form.

Disclaimer: Cannabis Investor News is for informational purposes only—not investment advice. We are not registered with the SEC, FINRA, or any regulatory body. Data may be delayed or inaccurate. Cannabis securities carry significant risk; you could lose your entire investment. Always consult a licensed financial advisor and verify all information independently before making any investment decision.

CIN Methodology — Data Sources and Editorial Standards

Cannabis Investor News maintains rigorous data sourcing, verification, and editorial standards designed to meet institutional-grade requirements for accuracy, timeliness, and transparency. Our methodology page documents the data providers, calculation methods, and quality controls that underpin every metric and analysis published on the CIN platform.

Market data is sourced from verified financial data providers delivering exchange-level pricing from NYSE, NASDAQ, CBOE, CSE, and OTC Markets. Analyst estimates are aggregated from institutional research platforms covering sell-side and independent research firms. Financial statement data is extracted from SEC EDGAR filings (10-K, 10-Q, 8-K) and Canadian SEDAR disclosures, then normalized for cross-border comparability. The Cannabis Market Health Index (CMHI) methodology is transparent and rules-based, combining price momentum signals, analyst sentiment scoring, capital market activity metrics, and regulatory catalyst proximity into a weighted composite. Component weightings and scoring thresholds are documented to ensure reproducibility and institutional credibility.

CIN's automated market briefs are generated by a rule-based engine that synthesizes live market data, macro signals, and analyst inputs — not by generalized AI language models producing speculative commentary. Every published brief passes a validation guard ensuring content completeness, data accuracy, and protection against placeholder or broken data reaching distribution channels. CIN is not a registered investment adviser and does not provide personalized investment recommendations.